TEVA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.55%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $15,236,840.56

Teva Pharmaceutical Industries Insider Trading History Chart

Teva Pharmaceutical Industries Share Price & Price History

^$22.09

▲ +0.78 (3.66%)

As of 12/20/2024 06:45 PM ET

Days: 30 | 90 | 365

Missed Nvidia? Buy Elon Musk’s “Silent Partner”

From Brownstone Research | Ad

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.

Teva Pharmaceutical Industries Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/20/2024	Christine Fox	EVP	Sell	19,388	$16.87	$327,075.56	44,104
8/1/2024	Eric A Hughes	Insider	Sell	24,537	$17.25	$423,263.25	45,060
6/18/2024	Roberto Mignone	Director	Sell	519,000	$17.03	$8,838,570.00	981,000
5/15/2024	Amir Weiss	CAO	Sell	15,500	$16.80	$260,400.00	17,814
5/13/2024	Vikki L. Conway	Insider	Sell	15,219	$16.74	$254,766.06
3/5/2024	Mark Sabag	EVP	Sell	100,000	$13.52	$1,352,000.00	382,590
2/28/2024	Eric Drape	VP	Sell	9,815	$13.12	$128,772.80	9,701
2/28/2024	Vikki L. Conway	Insider	Sell	1,366	$13.12	$17,921.92	2,928
2/16/2024	Eric Drape	VP	Sell	173,261	$13.05	$2,261,056.05	1
2/15/2024	Richard D. Francis	CEO	Sell	74,530	$13.15	$980,069.50	87,125
2/1/2024	Amir Weiss	CAO	Sell	31,766	$12.37	$392,945.42	10,676
8/7/2023	Eliyahu Sharon Kalif	CFO	Sell	35,125	$9.73	$341,766.25	99,162
8/4/2023	Amir Weiss	CAO	Sell	1,981	$9.92	$19,651.52	42,442
8/1/2023	Eric A. Hughes	insider	Sell	52,742	$8.30	$437,758.60
3/6/2023	David Matthew Stark	VP	Sell	16,491	$9.93	$163,755.63	52,449
3/6/2023	Sven Dethlefs	EVP	Sell	19,355	$9.93	$192,195.15	223,447
2/28/2023	David Matthew Stark	VP	Sell	63,383	$9.89	$626,857.87	2,974
2/28/2023	Sven Dethlefs	EVP	Sell	59,655	$9.89	$589,987.95	165,381
8/22/2022	Eliyahu Sharon Kalif	CFO	Sell	55,500	$10.07	$558,885.00	9,376
7/28/2022	David Matthew Stark	VP	Sell	58,163	$9.04	$525,793.52	2,974
5/17/2022	Hafrun Fridriksdottir	VP	Sell	130,000	$8.22	$1,068,600.00	1,387
2/28/2022	David Matthew Stark	VP	Sell	6,452	$8.14	$52,519.28
2/28/2022	Eli Shani	EVP	Sell	5,311	$8.14	$43,231.54
2/9/2022	David Matthew Stark	VP	Sell	6,110	$9.06	$55,356.60
2/9/2022	Sven Dethlefs	EVP	Sell	4,138	$9.06	$37,490.28

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for Teva Pharmaceutical Industries (NYSE:TEVA)

54.05% of Teva Pharmaceutical Industries stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Teva Pharmaceutical Industries Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	89,719	$1.62M	0.0%	-16.5%	0.008%
12/13/2024	Lord Abbett & CO. LLC	1,444,247	$26.03M	0.1%	-11.6%	0.127%
12/10/2024	DGS Capital Management LLC	13,627	$0.25M	0.1%	+6.8%	0.001%
11/27/2024	Franklin Resources Inc.	155,091	$2.67M	0.0%	+141.7%	0.014%
11/26/2024	Peapack Gladstone Financial Corp	11,267	$0.20M	0.0%	-27.0%	0.001%
11/25/2024	Tidal Investments LLC	13,856	$0.25M	0.0%	-67.4%	0.001%
11/25/2024	Wilmington Savings Fund Society FSB	2,759	$50K	0.0%	N/A	0.000%
11/25/2024	Sanctuary Advisors LLC	35,129	$0.60M	0.0%	+1.9%	0.003%
11/19/2024	TCW Group Inc.	71,390	$1.29M	0.0%	N/A	0.006%
11/16/2024	Geode Capital Management LLC	8,792,011	$157.57M	0.0%	+3.4%	0.776%
11/15/2024	Barclays PLC	427,595	$7.71M	0.0%	+31.7%	0.038%
11/15/2024	Public Employees Retirement System of Ohio	207,085	$3.73M	0.0%	N/A	0.018%
11/15/2024	Nomura Asset Management Co. Ltd.	313,238	$5.65M	0.0%	+7.7%	0.028%
11/15/2024	MML Investors Services LLC	36,529	$0.66M	0.0%	-13.5%	0.003%
11/15/2024	Dorsey Wright & Associates	168,862	$3.04M	0.7%	N/A	0.015%
11/15/2024	Orion Portfolio Solutions LLC	10,992	$0.20M	0.0%	N/A	0.001%
11/15/2024	XTX Topco Ltd	28,092	$0.51M	0.0%	-58.1%	0.002%
11/15/2024	National Bank of Canada FI	18,296	$0.33M	0.0%	-6.4%	0.002%
11/15/2024	iA Global Asset Management Inc.	440,891	$7.95M	0.1%	+5.2%	0.039%
11/15/2024	EP Wealth Advisors LLC	25,142	$0.45M	0.0%	N/A	0.002%
11/15/2024	United Services Automobile Association	37,477	$0.68M	0.0%	-8.9%	0.003%
11/15/2024	Wellington Management Group LLP	182,096	$3.28M	0.0%	-2.2%	0.016%
11/15/2024	Two Sigma Advisers LP	1,034,500	$18.64M	0.0%	+15.3%	0.091%
11/15/2024	Sphera Funds Management LTD.	2,130,216	$38.39M	6.1%	-47.5%	0.188%
11/15/2024	State Street Corp	19,500,683	$351.40M	0.0%	+10.0%	1.721%
11/15/2024	Stifel Financial Corp	66,391	$1.20M	0.0%	+54.0%	0.006%
11/15/2024	Quadrature Capital Ltd	168,023	$3.03M	0.1%	-59.8%	0.015%
11/15/2024	Quantinno Capital Management LP	36,145	$0.65M	0.0%	+34.5%	0.003%
11/15/2024	Point72 Asset Management L.P.	517,712	$9.33M	0.0%	-60.8%	0.046%
11/15/2024	Parkman Healthcare Partners LLC	285,294	$5.14M	0.7%	-19.4%	0.025%
11/15/2024	Parsifal Capital Management LP	6,232,971	$112.32M	7.7%	-6.9%	0.550%
11/15/2024	Maple Rock Capital Partners Inc.	4,559,401	$82.16M	2.3%	+1.0%	0.402%
11/15/2024	Investment Management Corp of Ontario	36,560	$0.66M	0.0%	-41.8%	0.003%
11/15/2024	Iron Triangle Partners LP	1,943,790	$35.03M	4.9%	-41.1%	0.172%
11/15/2024	Janus Henderson Group PLC	4,791,937	$86.35M	0.0%	+7,945.2%	0.423%
11/15/2024	HighTower Advisors LLC	148,605	$2.68M	0.0%	+461.8%	0.013%
11/15/2024	HighVista Strategies LLC	85,100	$1.53M	0.5%	-37.7%	0.008%
11/15/2024	Holocene Advisors LP	2,212,083	$39.86M	0.2%	-51.8%	0.195%
11/15/2024	Centiva Capital LP	50,037	$0.90M	0.0%	+3.1%	0.004%
11/15/2024	Cinctive Capital Management LP	233,495	$4.21M	0.2%	+43.8%	0.021%
11/14/2024	Bellevue Group AG	70,821	$1.28M	0.0%	-54.2%	0.006%
11/14/2024	Maverick Capital Ltd.	68,779	$1.24M	0.0%	+5.0%	0.006%
11/14/2024	Fred Alger Management LLC	142,351	$2.57M	0.0%	N/A	0.013%
11/14/2024	Goldentree Asset Management LP	2,304,993	$41.46M	3.3%	-7.3%	0.203%
11/14/2024	Captrust Financial Advisors	15,786	$0.28M	0.0%	+48.4%	0.001%
11/14/2024	Sio Capital Management LLC	1,349,274	$24.31M	9.6%	N/A	0.119%
11/14/2024	Northwest & Ethical Investments L.P.	10,000	$0.18M	0.0%	+108.3%	0.001%
11/14/2024	Vinva Investment Management Ltd	217,720	$3.80M	0.2%	+964.6%	0.019%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	3,377,517	$60.86M	0.0%	+237.5%	0.298%
11/14/2024	Public Sector Pension Investment Board	580,967	$10.47M	0.1%	+23.4%	0.051%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	453,251	$8.17M	0.0%	+3.3%	0.040%
11/14/2024	MetLife Investment Management LLC	95,025	$1.71M	0.0%	-9.6%	0.008%
11/14/2024	BNP Paribas	7,918	$0.14M	0.0%	+1,031.1%	0.001%
11/14/2024	Blueshift Asset Management LLC	41,086	$0.74M	0.2%	N/A	0.004%
11/13/2024	Rubric Capital Management LP	16,005,498	$288.42M	4.7%	-7.3%	1.413%
11/13/2024	Bridgewater Associates LP	23,222	$0.42M	0.0%	+5.2%	0.002%
11/13/2024	Freedom Investment Management Inc.	32,990	$0.59M	0.0%	-4.8%	0.003%
11/13/2024	Townsquare Capital LLC	39,350	$0.71M	0.0%	N/A	0.003%
11/13/2024	BNP Paribas Financial Markets	1,168,771	$21.06M	0.0%	-31.9%	0.103%
11/13/2024	D.A. Davidson & CO.	86,511	$1.56M	0.0%	+6.5%	0.008%
11/13/2024	FMR LLC	62,740,763	$1.13B	0.1%	+49.5%	5.538%
11/13/2024	Dai ichi Life Insurance Company Ltd	37,244	$0.67M	0.0%	-28.6%	0.003%
11/13/2024	The Manufacturers Life Insurance Company	432,402	$7.79M	0.0%	+5.9%	0.038%
11/13/2024	Bank of Montreal Can	408,015	$7.12M	0.0%	-1.4%	0.036%
11/13/2024	Daiwa Securities Group Inc.	89,465	$1.61M	0.0%	+10.0%	0.008%
11/12/2024	Centaurus Financial Inc.	17,891	$0.32M	0.0%	+27.7%	0.002%
11/12/2024	Swedbank AB	109,409	$1.97M	0.0%	-2.8%	0.010%
11/12/2024	Okabena Investment Services Inc.	58,776	$1.06M	0.3%	N/A	0.005%
11/12/2024	Pitcairn Co.	52,575	$0.95M	0.1%	N/A	0.005%
11/12/2024	Cerity Partners LLC	41,401	$0.75M	0.0%	-5.4%	0.004%
11/12/2024	Clal Insurance Enterprises Holdings Ltd	34,543,812	$621.34M	5.5%	+6.8%	3.049%
11/12/2024	Eagle Asset Management Inc.	38,857	$0.67M	0.0%	+41.5%	0.003%
11/12/2024	Charles Schwab Investment Management Inc.	899,175	$16.20M	0.0%	+24.7%	0.079%
11/12/2024	Smithfield Trust Co	2,739	$50K	0.0%	+55.7%	0.000%
11/9/2024	Intech Investment Management LLC	24,382	$0.44M	0.0%	N/A	0.002%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	823,544	$14.84M	0.1%	N/A	0.073%
11/8/2024	Factorial Partners LLC	311,000	$5.60M	3.2%	+14.3%	0.027%
11/8/2024	PNC Financial Services Group Inc.	59,255	$1.07M	0.0%	-4.4%	0.005%
11/8/2024	B. Metzler seel. Sohn & Co. Holding AG	25,249	$0.46M	0.0%	N/A	0.002%
11/8/2024	Banque Cantonale Vaudoise	5,910	$0.11M	0.0%	-58.6%	0.001%
11/8/2024	Prospera Financial Services Inc	41,674	$0.75M	0.0%	-25.1%	0.004%
11/7/2024	Caprock Group LLC	145,370	$2.62M	0.1%	+9.9%	0.013%
11/7/2024	Pathstone Holdings LLC	72,598	$1.31M	0.0%	+6.5%	0.006%
11/7/2024	Swiss National Bank	3,342,900	$60.24M	0.0%	+0.5%	0.295%
11/7/2024	Thrivent Financial for Lutherans	224,511	$4.05M	0.0%	+21.8%	0.020%
11/7/2024	Claro Advisors LLC	12,576	$0.23M	0.0%	N/A	0.001%
11/6/2024	Natixis Advisors LLC	168,867	$3.04M	0.0%	-16.1%	0.015%
11/6/2024	Cornercap Investment Counsel Inc.	41,074	$0.74M	0.2%	-36.3%	0.004%
11/6/2024	King Wealth Management Group	98,102	$1.77M	0.3%	N/A	0.009%
11/6/2024	CIBC Asset Management Inc	105,463	$1.90M	0.0%	+5.7%	0.009%
11/6/2024	Sargent Investment Group LLC	109,300	$1.97M	0.4%	-10.8%	0.010%
11/6/2024	Sivik Global Healthcare LLC	170,000	$3.06M	1.3%	-15.0%	0.015%
11/6/2024	Plato Investment Management Ltd	63,530	$1.14M	0.1%	N/A	0.006%
11/6/2024	D Orazio & Associates Inc.	11,023	$0.20M	0.0%	N/A	0.001%
11/6/2024	Oppenheimer & Co. Inc.	32,402	$0.58M	0.0%	+68.9%	0.003%
11/5/2024	Victory Capital Management Inc.	1,928,715	$34.76M	0.0%	+1.1%	0.170%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	1,963,561	$35.38M	0.0%	-0.5%	0.173%
11/5/2024	WCM Investment Management LLC	60,170	$1.05M	0.0%	N/A	0.005%
11/4/2024	Venturi Wealth Management LLC	3,302	$60K	0.0%	N/A	0.000%
11/4/2024	State of New Jersey Common Pension Fund D	473,509	$8.53M	0.0%	+3.7%	0.042%

Data available starting January 2016

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Today's Range

Now: $22.09

$21.11

$22.17

50 Day Range

MA: $17.79

$16.44

$22.09

52 Week Range

Now: $22.09

$10.34

$22.17

Volume

12,760,563 shs

Average Volume

9,444,773 shs

Market Capitalization

$25.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Teva Pharmaceutical Industries?: Teva Pharmaceutical Industries' top insider investors include:
Roberto Mignone (Director)
Mark Sabag (EVP)
Sven Dethlefs (EVP)
Eliyahu Sharon Kalif (CFO)
Richard D Francis (CEO)
David Matthew Stark (VP)
Eric A Hughes (Insider)
Christine Fox (EVP)
Amir Weiss (CAO)
Eric Drape (VP)
Vikki L Conway (Insider)
Eric A Hughes (Insider)
Vikki L Conway (Insider)
Learn More about top insider investors at Teva Pharmaceutical Industries.
Who are the major institutional investors of Teva Pharmaceutical Industries?: Teva Pharmaceutical Industries' top institutional investors include:
FMR LLC — 5.54%
Clal Insurance Enterprises Holdings Ltd — 3.05%
Migdal Insurance & Financial Holdings Ltd. — 2.25%
State Street Corp — 1.72%
Rubric Capital Management LP — 1.41%
Geode Capital Management LLC — 0.78%
Learn More about top institutional investors of Teva Pharmaceutical Industries stock.
Which institutional investors are selling Teva Pharmaceutical Industries stock?: During the previous quarter, TEVA stock was sold by these institutional investors:
Migdal Insurance & Financial Holdings Ltd.
Holocene Advisors LP
Sphera Funds Management LTD.
Iron Triangle Partners LP
Rubric Capital Management LP
Point72 Asset Management L.P.
AustralianSuper Pty Ltd
BNP Paribas Financial Markets
In the previous year, company insiders that have sold Teva Pharmaceutical Industries company stock include:
Roberto Mignone (Director)
Mark Sabag (EVP)
Sven Dethlefs (EVP)
Eliyahu Sharon Kalif (CFO)
Richard D Francis (CEO)
David Matthew Stark (VP)
Eric A Hughes (Insider)
Christine Fox (EVP)
Amir Weiss (CAO)
Learn More investors selling Teva Pharmaceutical Industries stock.
Which institutional investors are buying Teva Pharmaceutical Industries stock?: Within the last quarter, TEVA stock was acquired by institutional investors including:
FMR LLC
Janus Henderson Group PLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Clal Insurance Enterprises Holdings Ltd
State Street Corp
National Pension Service
Sio Capital Management LLC
Assenagon Asset Management S.A.